Feasibility and potential acceptability of three cervical barriers among vulnerable young women in Zimbabwe

Journal of Family Planning and Reproductive Health Care

Volumn 36, Issue 1, 2010, Pages 13-19

  Van Der Straten, Ariane ^a,b   Sahin Hodoglugil, Nuriye ^c   Clouse, Kate ^d   Mtetwa, Sibongile ^e   Chirenje, Mike Z ^e  

^a RTI INTERNATIONAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Venture Strategies for Health and Development   (United States)

^d IL   (United States)

^e UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

Acceptability; Cervical barrier method; Contraception; HIV prevention; Young women

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; CLINICAL PRACTICE; CONTRACEPTION; CONTROLLED STUDY; FEMALE; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; PREGNANCY; UTERINE CERVIX CAP; WOMEN'S HEALTH; ZIMBABWE;

ADOLESCENT; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS AS TOPIC; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; VULNERABLE POPULATIONS; YOUNG ADULT; ZIMBABWE;

EID: 76149125497     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118910790290966     Document Type: Article

References (49)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO). AIDS Epidemic Update: December 2006. Geneva, Switzerland: UNAIDS/WHO, 2006.
2. Laga M, Schartlender B, Pisani E, Sow PS, Carael M. To stem HIV in Africa, prevent transmission to young women. AIDS 2001; 15: 931-934.
3. Gregson S, Nyamukapa CA, Garnett GP, Mason PR, Zhuwau T, Carael M, et al. Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet. 2002; 359: 1896-1903.
4. Pettifor AE, Measham DM, Rees HV, Padian NS. Sexual power and HIV risk, South Africa. Emerg Infect Dis 2004; 10: 1996-2004.
5. Stein ZA. HIV prevention: the need for methods women can use. Am J Public Health 1990; 80: 460-462.
6. Central Statistical Office (CSO) (Zimbabwe), Macro International Inc. Zimbabwe Demographic and Health Survey 2005-2006. Calverton, MD: CSO and Macro International Inc., 2007.
7. Johnson B, Ndhlovu S, Farr S, Chipato T. Reducing unplanned pregnancy and abortion in Zimbabwe through postabortion contraception. Stud Fam Plann 2002; 33: 195-202.
8. Cates W, Stewart F. Vaginal barriers: the female condom, diaphragm, contraceptive sponge, cervical cap, Lea's Shield and Femcap (Chapter 18). In: Hatcher RA, Trussell J, Stewart FH, Nelson AL, Cates W Jr, Guest F, et al. (eds), Contraceptive Technology (18th edn), New York, NY: Ardent Media, 2004.
9. Warner L, Hatcher RA, Steiner MJ. Male condoms (Chapter 16). In: Hatcher RA, Trussell J, Stewart FH, Nelson AL, Cates W Jr, Guest F, et al. (eds), Contraceptive Technology (18th edn), New York, NY: Ardent Media, 2004.
10. Ellertson C, Burns M. Re-examining the role of cervical barrier devices. OUTLOOK 2003; 20(2): 1-8. http://www.path.org/files/eol20-2.pdf [Accessed 11 September 2009].
11. Moench TR, Chipato T, Padian NS. Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices. AIDS 2001; 15: 1595-1602.
12. Pudney J, Quayle AJ, Anderson DJ. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 2005; 73: 1253-1263.
13. Behets F, Van Damme K, Turner A, Rabenja N, Ravelomanana N, Raharinivo M, et al. Evidence-based planning of a randomized controlled trial on diaphragm use for prevention of sexually transmitted infections. Sex Transm Dis 2008; 35: 238-242.
14. Luchters S, Chersich MF, Jao I, Schroth A, Chidagaya S, Mandaliya K, et al. Acceptability of the diaphragm in Mombasa Kenya: a 6-month prospective study. Eur J Contracept Reprod Health Care 2007; 16: 1-9.
15. van der Straten A, Kang M, Posner SF, Kamba M, Chipato T, Padian NS. Predictors of diaphragm use as a potential sexually transmitted disease/HIV prevention method in Zimbabwe. Sex Transm Dis 2005; 32: 64-71.
16. van der Straten A, Napierala S, Cheng H, Mauck C, Depineres T, Dhlakama P, et al. A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe. Contraception 2007; 76:389-399.
17. Jewell N, van der Straten A, Montgomery E, Rosenblum M, Padian N. Diaphragms and lubricant gel for prevention of HIV [Author Reply]. Lancet 2007; 370: 1823-1824.
18. Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007; 370: 251-261.
19. Ramjee G, van der Straten A, Chipato T, de Bruyn G, Blanchard K, Shiboski S, et al. The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial. PLoS One 2008; 3(10): e3488.
20. Padian NS, Buvé A, Balkus J, Serwadda D, Cates W Jr. Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. Lancet 2008; 372: 585-599.
21. Pretorius ES, Timbers K, Malamud D, Barnhart K. Magnetic resonance imaging to determine the distribution of a vaginal gel: before, during, and after both simulated and real intercourse. Contraception 2002; 66: 443-451.
22. Mauck C, Callahan M, Weiner DH, Dominik R. A comparative study of the safety and efficacy of FemCap, a new vaginal barrier contraceptive, and the Ortho All-Flex diaphragm. The FemCap Investigators' Group. Contraception 1999; 60: 71-80.
23. Shihata AA. The FemCap: a new contraceptive choice. Eur J Contracept Reprod Health Care 1998; 3: 160-166.
24. Schwartz JL, Mauck CK, Rountree RW, Ballagh SA, Creinin MD, Kilbourne-Brook M. SILCS diaphragm: postcoital testing of a new single-size contraceptive diaphragm. Obstet Gynecol 2006; 107(4 Suppl.): 12S.
25. CONRAD. Contraceptive Effectiveness and Safety of the SILCS Diaphragm. http://clinicaltrials.gov/ct2/show/NCT00578877?term= SILCS+contraceptive+effectiveness+study&rank=1 [Accessed 11 September 2009].
26. Behets F, Turner A, Van Damme K, Rabenja N, Ravelomanana N, Zeller K, et al. Acceptability and feasibility of continuous diaphragm use among sex workers in Madagascar. Sex Transm Infect 2005; 81: 472-476.
27. Bukusi E, Sharma A, Njoroge B, Tevi- Bennisan C, Duerr A, Cohen C. Acceptability of the diaphragm among women in an ongoing sexually transmitted infection efficacy trial. Paper presented at the International Society for Sexually Transmitted Diseases Research (ISSTDR) 15th Biennial Conference, Ottawa, Canada, 27-30 July 2003.
28. Bulut A, Ortayli N, Ringheim K, Cottingham J, Farley TM, Peregoudov A, et al. Assessing the acceptability, service delivery requirements, and use-effectiveness of the diaphragm in Colombia, Philippines, and Turkey. Contraception 2001; 63: 267-275.
29. Sharma A, Bukusi E, Posner S, Feldman D, Ngugi E, Cohen CR. Sex preparation and diaphragm acceptability in sex work in Nairobi, Kenya. Sex Health 2006; 3: 261-268.
30. Coffey PS, Kilbourne-Brook M, Austin G, Seamans Y, Cohen J. Short-term acceptability of the PATH Woman's Condom among couples at three sites. Contraception 2006; 73: 588-593.
31. Coffey PS, Kilbourne-Brook M, Brache V, Cochón L. Comparative acceptability of the SILCS and Ortho ALL-FLEX® diaphragms among couples in the Dominican Republic. Contraception 2008; 78: 418-423.
32. Hardy E, de Padua KS, Jimenez AL, Zaneveld LJ. Women's preferences for vaginal antimicrobial contraceptives. II. Preferred characteristics according to women's age and socioeconomic status. Contraception 1998; 58: 239-244.
33. Montandon M, Sahin-Hodoglugil N, Bukusi E, Agot K, Boland B, Cohen C. Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya. Sex Health 2008; 5: 339-346.
34. Rosenthal SL, Cohen SS, Stanberry LR. Topical microbicides. Current status and research considerations for adolescent girls. Sex Transm Dis 1998; 25: 368-377.
35. Rupp RE, Rosenthal SL. Vaginal microbicides and teenagers. Curr Opin Obstet Gynecol 2003; 15: 371-375.
36. Sahin-Hodoglugil N, van der Straten A, Mtetwa S, Clouse K, Chirenje T, Nyambo V, et al. "AIDS is a body lotion": HIV risk and attitudes towards cervical barriers as a potential method of HIV prevention among young women in Zimbabwe. Poster presentation at the National HIV Prevention Conference, Atlanta, GA, USA, 2-5 December 2007.
37. Bradford LJ, Beck KH. Development and validation of a condom self-efficacy scale for college students. J Am Coll Health 1991; 39: 219-225.
38. Harvey SM, Bird ST, Maher JE, Beckman LJ. Who continues using the diaphragm and who doesn't: implications for the acceptability of female-controlled HIV prevention methods. Womens Health Issues 2003; 13: 185-193.
39. Mtetwa S, Chirenje T, Nyambo V, Clouse K, Sahin-Hodoglugil N, Chirenje M, et al. Feasibility and acceptability of cervical barriers among vulnerable youth in Africa. Poster presentation at the 3rd South African AIDS Conference, Durban, South Africa, 5-8 June 2007.
40. Mauck CK, Weiner DH, Creinin MD, Archer DF, Schwartz JL, Pymar HC, et al. FemCap with removal strap: ease of removal, safety and acceptability. Contraception 2006; 73: 59-64.
41. Epstein LB, Sokal-Gutierrez K, Ivey SL, Raine T, Auerswald C. Adolescent experiences with the vaginal ring. J Adolesc Health 2008; 43: 64-70.
42. Ballagh S, Brache V, Mauck C, Callahan M, Cochon L, Wheeless A, et al. A Phase 1 study of the functional performance, safety, and acceptability of the BufferGel Duet. Contraception 2007; 77: 130-137.
43. Montgomery CM. The role of partnership dynamics in determining the acceptability of condoms and microbicides. AIDS Care 2008; 20: 733-740.
44. Salter ML, Go VF, Celentano DD, Diener-West M, Nkhoma CM, Kumwenda N, et al. The role of men in women's acceptance of an intravaginal gel in a randomized clinical trial in Blantyre, Malawi: a qualitative and quantitative analysis. AIDS Care 2008; 7: 853-862.
45. van der Straten A, Moore J, Napierala S, Clouse K, Mauk C, Hammond N, et al. Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbicide in Harare, Zimbabwe. Contraception 2008; 77: 435-443.
46. Buck J, Kang MS, van der Straten A, Khumalo-Sakutukwa G, Posner S, Padian N. Barrier method preferences and perceptions among Zimbabwean women and their partners. AIDS Behav 2005; 9: 415-422.
47. Okal J, Stadler J, Ombidi W, Jao I, Luchters S, Temmerman M, et al. Secrecy, disclosure and accidental discovery: perspectives of diaphragm users in Mombasa, Kenya. Cult Health Sex 2008; 10: 13-26.
48. Woodsong C, Alleman P. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi. AIDS Educ Prev 2008; 20: 171-187.
49. Stewart F. Vaginal barriers: the diaphragm, contraceptive sponge, cervical cap and female condom (Chapter 18). In: Hatcher RA, Trussell J, Stewart F, Willard JC, Stewart GK, Guest F, et al. (eds), Contraceptive Technology (17th edn). New York, NY: Ardent Media Inc., 1998.